Abstract
During the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), which was held on 18 and 19 of January, 2018, in Cairo, Egypt, around 100 international, regional and national experts presented the latest updates in breast cancer, gynaecological cancers and immunotherapy in oncology. Through this report, we will try to highlight the important data and consensus issues that were discussed during the conference.
Highlights
The Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), which was held during the period of 18 to 19 January, 2018, in Cairo, Egypt, was celebrating its 10th round this year
The BGICC is one of the international multi-disciplinary conferences dedicated to fostering the science of Breast and Gynaecological oncology and improving the care of cancer patients and their families throughout the world
We will present the highlights of the important data presented during the 10th BGICC, with special consideration to triple negative breast cancer (TNBC), management of Her2 positive disease, breast cancer prevention, the BGICC consensus sessions and the BGICC education courses
Summary
Received: 06/02/2018 ecancer 2018, 12:820 https://doi.org/10.3332/ecancer.2018.820 Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
